Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Share:
Related CVS
Canaccord Reiterates On Alere, Boosts Price Target To $60
Benzinga's M&A Chatter for Thursday May 21, 2015
Ulta Beauty's Earnings Growth Keeps Getting Prettier (Investor's Business Daily)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

DateFirmActionFromTo
Apr 2015JefferiesMaintainsBuy
Feb 2015CitigroupMaintainsNeutral
Feb 2015Deutsche BankMaintainsHold

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

Around the Web, We're Loving...

Get Benzinga's Newsletters